ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3060

The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center

Handan Yarkan1, Sedanur Karaman2, Pinar Cetin1, Servet Akar3, Aytac Gulcu4, Ahmet Yigit Goktay4, Gercek Can1, Merih Birlik1, Nurullah Akkoc5 and Fatos Onen1, 1Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 2Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 3Department of Internal Medicine, Division of Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, 4Radiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 5Department of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Doppler ultrasound, Magnetic resonance imaging (MRI), radiology and takayasu arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim of this study is to analyze the activity parameters that affect the physicians global opinion (PGO) in TA.

Methods: The data of patients with TA who were followed in the Rheumatology outpatient clinic were retrospectively evaluated. Disease activity was assessed with, National İnstitutes of Healty (NIH)  criteria, disease extent index-Takayasu (DEI.Tak), the Indian Takayasu Activity Score (ITAS2010), PGO, radiological activity parameters, and acute-phase reactants. According to the TA follow-up protocol of the Rheumatology and Radiology Board of our hospital, the patients were followed using B-mode/Doppler USG examinations and magnetic resonance angiography (MRA).

Results: 52 patients (48 females; mean age:46.8±13.2 years) who fulfilled the American College of Rheumatology(ACR) criteria for TA were enrolled in this study. 40 (76.9%) patients were categorized as having active disease in their first visits according to PGO. In the last visit, 31 (59.6%) patients had inactive disease, 19 (36.5%) had persistent disease and two (%3.9) had active disease. All the patients used the long-term glucocorticoid therapy and DMARDs. Six (%11.5) of them were on the treatment with biologics. Six (11.5%) patients underwent vascular surgery and 26 (50%) were performed endovascular repair for arterial stenosis. In total, 360 visits of patients were evaluated. PGO was that the disease was inactive in the 181 visits, persistan in the 99 visits and active in the 80 visits. The highest aggreement was found between PGO and the results of MRA and also B-mode/Doppler USG. NIH activation, DEI.Tak and ITAS2010 scores also well correlated with PGO. There was a poor agreement between PGO and hs-CRP.

Conclusion: The results of this study suggest that imaging had a significant impact on physician’s decision regarding disease activity in TA. Although disease activity scores including radiological activity parameters, NIH, DEI-Tak and ITAS2010 were well correlated with each other, there was a poor agreement between CRP and all the other activity parameters.

Table 1.Agreement rates and correlations of the disease activity parameters with each other and PGO in Takayasu arteritis

 

Hs-CRP

ITAS2010

Score

DEI.Tak

Score

NIH

Score

Positive B mode/

Doppler US

Positive

MRI

PGO

Hs-CRP

 

0.2**

0.19**

0.29*

0.19*

0.32*

0.32*

ITAS2010

score

0.2**

 

 

0.93**

 

0.68**

0.47**

0.43**

0.55**

DEI.Tak

score

0.19**

 

0.93**

 

 

0.70**

0.47**

0.44**

0.54**

NIH

score

0.29*

 

0.68**

 

0.70**

 

0.55*

0.51*

 

0.64*

Positive B mode/

Doppler US

0.19*

0.47**

0.47**

0.55*

 

0.53*

 

0.80*

Positive

MRA

0.32*

0.43**

0.44**

0.51*

0.53*

 

 

0.79*

*kappa statistic, **Spearman ro.  All p values were <0.05.


Disclosure: H. Yarkan, None; S. Karaman, None; P. Cetin, None; S. Akar, None; A. Gulcu, None; A. Y. Goktay, None; G. Can, None; M. Birlik, None; N. Akkoc, None; F. Onen, None.

To cite this abstract in AMA style:

Yarkan H, Karaman S, Cetin P, Akar S, Gulcu A, Goktay AY, Can G, Birlik M, Akkoc N, Onen F. The Assessment of Disease Activity in Takayasu Arteritis; Six Years Experience from a Single Center [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-assessment-of-disease-activity-in-takayasu-arteritis-six-years-experience-from-a-single-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-assessment-of-disease-activity-in-takayasu-arteritis-six-years-experience-from-a-single-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology